High-titer collapsin response-mediating protein-associated (CRMP-5) paraneoplastic optic neuropathy and Vitritis as the only clinical manifestations in a patient with small cell lung carcinoma.

Paraneoplastic optic neuropathy (PON) is a rare syndrome usually associated with small cell lung carcinoma. In the 27 rigorously reported cases, neurologic manifestations other than visual loss have been present in all but 2. In the single case in which vision improved in response to treatment of the cancer, the collapsin response-mediating protein (CRMP)-5 titer did not change, and the ophthalmic examination was not detailed. We describe a patient with optic neuropathy and vitritis as the only clinical manifestations of PON marked by an extremely high titer of CRMP-5 antibody. Treatment of the underlying small cell lung cancer coincided with resolution of the visual abnormalities and a dramatic decrease in the CRMP-5 titer.

[1]  C. Vedeler,et al.  Treatment of Paraneoplastic Neurological Syndromes , 2009 .

[2]  F. Ducray,et al.  Devic’s syndrome-like phenotype associated with thymoma and anti-CV2/CRMP5 antibodies , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[3]  A. Saiz,et al.  Isolated paraneoplastic optic neuropathy associated with small-cell lung cancer and anti-CV2 antibodies , 2007, Journal of Neurology.

[4]  R. Sheorajpanday,et al.  Small cell lung carcinoma presenting as collapsin response-mediating protein (CRMP) -5 paraneoplastic optic neuropathy. , 2006, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[5]  P. C. Calvert A CR(I)MP in the optic nerve: recognition and implications of paraneoplastic optic neuropathy. , 2006, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[6]  J. Dalmau,et al.  Paraneoplastic disorders of the central nervous system: update on diagnostic criteria and treatment. , 2004, Seminars in neurology.

[7]  V. Lennon,et al.  Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome , 2004, Annals of neurology.

[8]  A. Samii,et al.  Paraneoplastic movement disorder in a patient with non‐Hodgkin's lymphoma and CRMP‐5 autoantibody , 2003, Movement disorders : official journal of the Movement Disorder Society.

[9]  J. Parisi,et al.  Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP‐5‐IgG , 2003, Annals of neurology.

[10]  C. Adler,et al.  Paraneoplastic chorea associated with CRMP‐5 neuronal antibody and lung carcinoma , 2002, Annals of neurology.

[11]  N. Newman,et al.  Paraneoplastic optic neuropathy and cerebellar ataxia with small cell carcinoma of the lung. , 2001, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[12]  E. Benarroch,et al.  CRMP‐5 neuronal autoantibody: Marker of lung cancer and thymoma‐related autoimmunity , 2001, Annals of neurology.

[13]  J. Honnorat,et al.  Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, Anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone , 2000, Journal of neurology, neurosurgery, and psychiatry.

[14]  J. Guy,et al.  Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases. , 1999, Archives of ophthalmology.

[15]  J. Keltner,et al.  Paraneoplastic Optic Neuropathy and Autoantibody Production in Small‐Cell Carcinoma of the Lung , 1998, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[16]  C. Thirkill,et al.  Paraneoplastic Retinopathy: A Novel Autoantibody Reaction Associated with Small‐cell Lung Carcinoma , 1997, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[17]  H. Sugihara,et al.  Autopsy report of acute necrotizing opticomyelopathy associated with thyroid cancer , 1993, Journal of the Neurological Sciences.

[18]  A. Furlan,et al.  Optic neuropathy: a rare paraneoplastic syndrome. , 1992, Journal of clinical neuro-ophthalmology.

[19]  A. Roth,et al.  Management and monitoring of cancer-associated retinopathy. , 1992, Archives of ophthalmology.

[20]  T. Hoogenraad,et al.  Paraneoplastic optic neuropathy with histopathological verification of absence of meningeal metastases , 1989 .